Advanced Solid Tumors Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Advanced Solid Tumors
  • Liverpool, New South Wales, Australia
  • +15 more
2022-04-07
Apr 7, 2022
A
Recruiting
  • Advanced Solid Tumors
  • AMG 994
  • AMG 404
  • Duarte, California
  • +16 more
2022-04-06
Apr 6, 2022
N
Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Fairway, Kansas
  • +1 more
2022-04-07
Apr 7, 2022
I
E
Completed
  • Advanced Solid Tumors
  • MSC2490484A (M3814)
  • +2 more
  • Fresno, California
  • +25 more
2022-04-06
Apr 6, 2022
K
Recruiting
  • Advanced Solid Tumors
  • KSQ-4279
  • KSQ-4279 will be combined in separate cohorts, including combination with an oral PARPi (poly adenosine diphosphate-ribose polymerase inhibitor)
  • Boston, Massachusetts
  • +4 more
2022-04-05
Apr 5, 2022
S
Active, not recruiting
  • Advanced Solid Tumors
  • +4 more
  • Phoenix, Arizona
  • +15 more
2022-04-04
Apr 4, 2022
S
Recruiting
  • Advanced Solid Tumors
  • Sarcoma
  • Los Angeles, California
  • +9 more
2022-04-04
Apr 4, 2022
S
Recruiting
  • Advanced Solid Tumors
  • JS108 (recombinant humanized anti-Trop2 mAb-Tub196 conjugate for injection)
  • Beijing, Beijing, China
  • +2 more
2022-04-01
Apr 1, 2022
S
Completed
  • Advanced Solid Tumors
  • Houston, Texas
  • +2 more
2022-04-04
Apr 4, 2022
S
Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +4 more
2022-04-04
Apr 4, 2022
S
Completed
  • Cancer
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +10 more
2022-04-04
Apr 4, 2022
J
Recruiting
  • Advanced Solid Tumors
  • Camrelizumab for Injection, Famitinib malate capsule, Paclitaxel For Injection(Albumin Bound)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
2022-04-02
Apr 2, 2022
A
Active, not recruiting
  • Advanced Solid Tumors
  • La Jolla, California
  • +25 more
2022-03-23
Mar 23, 2022
A
Active, not recruiting
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +9 more
2022-03-23
Mar 23, 2022
A
Active, not recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +11 more
2022-03-31
Mar 31, 2022
A
Recruiting
  • Advanced Solid Tumors
  • AMG 256
  • Duarte, California
  • +9 more
2022-03-30
Mar 30, 2022
A
Active, not recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • ALKS 4230 + pembrolizumab
  • Denver, Colorado
  • +30 more
2022-03-29
Mar 29, 2022
D
Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Grand Rapids, Michigan
  • +3 more
2022-03-30
Mar 30, 2022